Saturday 17 October 2026 Export SLN’s income statement to Excel — free account

Silence Therapeutics PLC Sponsored ADR

Silence Therapeutics PLC Sponsored ADR’s revenue for fiscal 2025 (year ended December 2025) was $559,000.00, down 98.7% from fiscal 2024. In the quarter to June 2026, revenue grew 197.2%, EPS grew 54.4% and free cash flow grew 107.0%, each against the same quarter a year earlier.

8.68 0.67 −7.17%

Follow SLN

Alert me

Market cap: $581.1M
P/E: 0.0×
Fwd P/E: −7.6×
Dividend yield: —
F-score: 2/9
Altman Z: −4.82
Beneish M: 45.78
Dividend safety: n/a

Overview Business Profile Financial Analysis Income Statement Balance Sheet Cash Flow Metrics & Ratios 10-Q 10-K

	Jun '26	Mar '26	Dec '25	Sep '25	Older periods
P/E ratio Full definition →	—	0.00	0.00	0.00	+8 more quarters Free account
P/S ratio Full definition →	—	296.69	513.72	9.49
P/FCF ratio Full definition →	—	0.00	0.00	0.00
P/Operating CF Full definition →	—	(15.95)	(16.61)	(22.51)
P/B ratio Full definition →	—	0.00	4.61	3.31
Price to Tangible BV Full definition →	—	0.00	5.59	3.88
EV/Sales Full definition →	—	213.24	361.63	5.54
EV/EBITDA Full definition →	—	0.00	0.00	0.00
EV/Operating CF Full definition →	—	(2.73)	(3.25)	(1.97)
EV/FCF Full definition →	—	(2.73)	(3.24)	(1.97)
Quick Ratio Full definition →	6.40	8.82	7.87	7.16
Current Ratio Full definition →	7.42	9.83	8.72	7.69
Net Debt/EBITDA Full definition →	5.24	4.48	6.89	3.92
Debt/Assets Full definition →	0.00%	0.04%	0.05%	0.00%
Debt/Equity Full definition →	0.00	0.00	0.00	0.00
Asset Turnover Full definition →	0.00	0.01	0.00	0.14
Operating CF/Net income Full definition →	(0.12)	1.04	1.47	0.52
Capex/Depreciation Full definition →	0.00	0.00	0.00	(0.02)
Research and Development Expense of Revenue Full definition →	0.00%	2,161.61%	25,732.35%	12,920.75%
Selling, General and Administrative Expense of Revenue Full definition →	0.00%	1,664.93%	10,982.35%	3,644.65%
Intangible Assets out of Total Assets Full definition →	0.10	0.09	0.08	0.07
Share Based Compensation of Revenue Full definition →	0.00%	579.86%	(252.94%)	1,594.34%
Graham Net Nets Full definition →	—	0.15	0.17	0.25
Graham Number Full definition →	—	6.12	0.00	0.00
Earnings Yield Full definition →	—	(30.17%)	(30.76%)	(26.01%)
Free Cash Flow Yield Full definition →	—	(26.36%)	(21.70%)	(29.61%)
Revenue per Share Full definition →	0.00	0.01	0.00	0.00
Operating CF per Share Full definition →	0.03	(0.33)	(0.37)	(0.23)
Capex per Share Full definition →	0.00	0.00	0.00	0.00
Free Cash Flow per Share Full definition →	0.03	(0.33)	(0.37)	(0.23)
Cash per Share Full definition →	1.53	1.48	1.80	2.16
Shareholders Equity per Share Full definition →	0.81	1.05	1.32	1.57
Interest Debt per Share Full definition →	0.00	0.00	0.00	0.00
Book value per Share Full definition →	0.81	1.05	1.32	1.57
Free Cash Flow Full definition →	1.52	(15.60)	(17.29)	(10.89)
Working Capital Full definition →	81.57	92.39	105.05	116.25
Capital Expenditures Full definition →	—	—	0.00	0.00
Net Current Asset Value Full definition →	26.34	37.13	49.52	60.91
EV/EBIT Full definition →	—	0.00	0.00	0.00
Capex to Sales Full definition →	—	0.00	0.00	0.02
Price to Operating Income Full definition →	—	0.00	0.00	0.00
Other line items
Average Receivables Full definition →	14.67	19.53	23.69	21.86
Average Payables Full definition →	13.46	14.59	14.88	17.78
Average Assets Full definition →	135.82	150.21	167.04	183.54
Average Common Equity Full definition →	66.31	31.67	98.16	98.49

Fold the line items

Columns are period end dates

Stockrow Weekly